Loading…

Tuning the NLO response of bis-cyclometalated iridium() complexes by modifying ligands: experimental and structural DFT analysis

Density functional theory (DFT) calculations have been carried out to investigate two synthesized iridium( iii ) complexes with substituted Phbd (1-phenyl-2-(pyridin-2-yl)-1 H -benzo[ d ]imidazole) and Crbd (9-(4-(2-(pyridin-2-yl)-1 H -benzo[ d ]imidazol-1-yl)phenyl)-9 H -carbazole) as ancillary lig...

Full description

Saved in:
Bibliographic Details
Published in:New journal of chemistry 2021-03, Vol.45 (12), p.5491-5496
Main Authors: Akhtar, Mansoor, Arif, Ali Muhammad, Ullah Khan, Shifa, Shan, Guo-Gang, Xu, Hong-liang, Su, Zhong-Min
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Density functional theory (DFT) calculations have been carried out to investigate two synthesized iridium( iii ) complexes with substituted Phbd (1-phenyl-2-(pyridin-2-yl)-1 H -benzo[ d ]imidazole) and Crbd (9-(4-(2-(pyridin-2-yl)-1 H -benzo[ d ]imidazol-1-yl)phenyl)-9 H -carbazole) as ancillary ligands. The aim of this paper is to study the effect of the substituent on the geometrical structures, electronic and second-order nonlinear optical (NLO) properties, and UV-vis absorption spectra. It is found that the first hyperpolarizabilities can be easily modulated by the introduction of Phbd and Crbd units. The complex with Phbd possesses larger first hyperpolarizability values compared to the complex with Crbd as an ancillary ligand. Significantly, the changes in the first hyperpolarizabilities can be qualitatively explained by means of the charge transfer pattern. It is anticipated that the theoretical investigation of these iridium( iii ) complexes will be helpful for designing high performance and versatile NLO materials. DFT calculations have been carried out to investigate two synthesized iridium( iii ) complexes with substituted Phbd (1-phenyl-2-(pyridin-2-yl)-1 H -benzo[ d ]imidazole) and Crbd (9-(4-(2-(pyridin-2-yl)-1 H -benzo[ d ]imidazol-1-yl)phenyl)-9 H -carbazole) as ancillary ligands.
ISSN:1144-0546
1369-9261
DOI:10.1039/d1nj00114k